临床药师参与一例支原体肺炎患者治疗实践及分析

Clinical Pharmacists Participated in the Practice and Analysis of the Treatment of A Patient with Mycoplasma Pneumonia

目的:分析1例肺炎支原体肺炎患者治疗失败的原因,为临床治疗提供参考。方法:临床药师参与1例肺炎支原体肺炎患者治疗实践,发挥自身专业优势,分析、评估患者感染可能的致病原体及病原体耐药情况,当抗感染治疗不佳时,积极查阅文献,分析原因,参与抗感染方案调整。结果:临床药师建议停用阿奇霉素注射液,改用莫西沙星注射液继续抗感染治疗。医师采纳临床药师建议,患者病情得到控制。结论:临床药师参与临床治疗实践,可以更好的促进临床合理用药,保障患者用药安全。

Objective:To analyze the reasons of the failure treatment in one case of mycoplasma pneumoniae pneumonia(MPP)patients and to provide reference for clinical treatment.Methods:Clinical pharmacists participated in the treatment practice of MPP patients,giving full play to their professional advantages,analyzed and evaluated the patient's infection of possible pathogens and pathogen resistance.When anti-infective treatment was poor,actively consulted the literature,analyzed the reasons,participated in the adjustment of anti-infection program.Results:Clinical pharmacists recommend discontinuing azithromycin injections and switching to moxisin injections to continue anti-infection treatment.The recommendations of clinical pharmacists were adopted by physicians,the patient's condition was controlled.Conclusion:The participation of clinical pharmacists in clinical treatment practice can better promote rational drug use and ensure the medication safety of patients.